EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

The Effects of Drugs on CYP3A Enzyme Activity and Protein Expression Through Ubiquitination Modification Regulation

Fang Wang, Xiwei Gu, Haiying Hong, Qianqian Xia, Yuxin Zhang, Ying Song, Baoxin Li iD, Pan Fan

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.70102 ↗

At a glance

Journal article in Basic & Clinical Pharmacology & Toxicology, 2025. Written by Fang Wang and 7 co-authors. Institution: Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, China. Major MEDLINE topics: Cytochrome P-450 CYP3A, Cytochrome P-450 CYP3A Inhibitors, Hypoxia. 46 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Natural Science Foundation of China, Heilongjiang Natural Science Foundation Joint Guidance Project.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Cytochrome P450 3A4 (CYP3A4) is one of the most important members of the cytochrome P450 subfamily, which is involved in the catalytic process of many drug activation or deactivation. Meanwhile, it is also a risk factor for drug‐induced toxic reactions. Our research investigates the impact of drugs on CYP3A4 enzyme activity and protein expression, and that CYP3A4 inhibition induced by drugs may exacerbate under hypoxia. Molecular docking has found that the drug has binding sites with amino acid residues in the active region of CYP3A4, which may affect the ability of the CYP3A4 enzyme to metabolize drugs. Twenty male Sprague Dawley rats were divided into two groups: control (FiO 2 : 21%), hypoxia (FiO 2 : 10%) for 14 days. Liver microsomes from hypoxic and normoxic rats were used for in vitro experiments by high‐performance liquid chromatography. Drug concentration in blood in vivo was measured by LC–MS/MS. Further studies have revealed that drugs mediate the degradation of CYP3A4 ubiquitination‐proteasome pathway through E3 ubiquitin ligase gp78 by immunoprecipitation, which may exacerbate the CYP3A4 inhibition under hypoxic conditions. These elucidated that the inhibition of CYP3A4 may worsen under pathological conditions (such as hypoxia), providing a basis for rational clinical medication to reduce or avoid drug interactions and toxic reactions.

Subjects

MeSH terms (MEDLINE)

Cytochrome P-450 CYP3ACytochrome P-450 CYP3A InhibitorsHypoxiaAnimalsMaleRats, Sprague-DawleyUbiquitinationMolecular Docking SimulationRatsMicrosomes, LiverDrug Interactions

Author keywords

CYP3A4drug metabolismdrug safetyenzyme inhibitionubiquitination

Substances

Cytochrome P-450 CYP3ACytochrome P-450 CYP3A Inhibitors

Authors and institutions

  • Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, China.
  • Department of Ophthalmology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang Province, China.

ORCID profiles: Baoxin Li

Funding

  • National Natural Science Foundation of China
  • Heilongjiang Natural Science Foundation Joint Guidance Project

Cite

APA

Wang, F., Gu, X., Hong, H., Xia, Q., Zhang, Y., Song, Y., Li, B., & Fan, P. (2025). The Effects of Drugs on CYP3A Enzyme Activity and Protein Expression Through Ubiquitination Modification Regulation. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70102

Vancouver

Wang F, Gu X, Hong H, Xia Q, Zhang Y, Song Y, et al. The Effects of Drugs on CYP3A Enzyme Activity and Protein Expression Through Ubiquitination Modification Regulation. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70102

BibTeX
@article{Wang2025,
  author = {Wang, Fang and Gu, Xiwei and Hong, Haiying and Xia, Qianqian and Zhang, Yuxin and Song, Ying and Li, Baoxin and Fan, Pan},
  title = {The Effects of Drugs on CYP3A Enzyme Activity and Protein Expression Through Ubiquitination Modification Regulation},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.70102}
}
Start for free →